Academic Research Building

Fellowships


Hematology/Oncology Fellowship Program

William Slayton, MDThe Pediatric Hematology Oncology Fellowship Program was completely redesigned in 2002. We have a busy clinical service that provides strong exposure to pediatric hematology, oncology and stem cell transplantation including unrelated donor transplantation. We have well-developed clinical programs in sickle cell anemia, orthopedic oncology, leukemia treatment, stem cell transplantation, neuro-oncology and palliative care. Fellows will focus on clinical activities for the first 12-14 months of training, followed by 22-24 months of intensive research training involving an independent research project that can be laboratory based, translational, or involve clinical trials research in conjunction with the Children's Oncology Group Research Data Center located in Gainesville. Fellows have the opportunity to pursue research projects under the direction of faculty members from the pediatric hematology/oncology division or other faculty members at the University of Florida.

Sample Rotation Schedule

Fellowship Program Director
William Slayton, MD
Professor of Pediatrics, Division of Hematology/Oncology
Box 100296
Gainesville, Florida 32610-0296
Office: 352-392-5633 Fax: 352-392-8725
slaytwb@peds.ufl.edu

Faculty

Levette Dunbar, MD
Clinical Interests: Sickle Cell Disease, Severe Aplastic Anemia
Research Interests: Transfusion practices in the management of sickle cell disease, quality of life analysis in sickle cell disease

Vishwas Sakhalkar, MD
Clinical Interests: Sickle cell disease, hemostasis and thrombosis, benign hematology
Research Interests: Role and impact of Hydroxyurea and blood transfusion on sickle cell disease

William B. Slayton, MD
Clinical Interests: Leukemia; hematopoiesis
Research Interests: Leukemogenesis; thrombopoiesis; hematopoietic stem cell biology

Amy A. Smith, MD
Clinical Interests: Pediatric Brain Tumors
Research Interests: Fibrinolytic abnormalities associated with brain tumors; risk of associated intracranial hemorrhage; role fibrinolytic proteins play in tumor progression/metastasis